We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Dietary Intervention- Randomized Controlled Trial (DIRECT) Study; BGU-Harvard–Robarts Collaboration

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2006 by The S. Daniel Abraham International Center for Health and Nutrition.
Recruitment status was:  Active, not recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00160108
First Posted: September 12, 2005
Last Update Posted: September 13, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Harvard School of Public Health
University of Western Ontario, Canada
Soroka University Medical Center
Brigham and Women's Hospital
Harvard Medical School
The Nuclear Research Center, Dimona
Ben-Gurion University of the Negev
Information provided by:
The S. Daniel Abraham International Center for Health and Nutrition
  Purpose
Aim-to conduct a randomized clinical intervention study to compare three diets (low-fat, low-carbohydrate and Mediterranean diet) for weight loss

Condition Intervention Phase
Obesity CHD Behavioral: dietary intervention Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention

Further study details as provided by The S. Daniel Abraham International Center for Health and Nutrition:

Primary Outcome Measures:
  • weight loss

Secondary Outcome Measures:
  • CVD mediators measurements

Estimated Enrollment: 300
Study Start Date: July 2005
Estimated Study Completion Date: July 2007
Detailed Description:
Aim-to conduct a randomized clinical intervention study to compare three diets (low-fat, low-carbohydrate and Mediterranean diet) for weight loss
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   40 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • BMI>27
  • age>40
  • History of CHD or diabetes in any age or BMI level

Exclusion Criteria:

  • Pregnant or lactating women.
  • Active drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with adherence to study requirements.
  • Serum creatinine > 3 mg/dl.
  • Liver dysfunction ( ³ 2 fold level of ALT and AST enzymes).
  • Participation in another trial in which active intervention is being received.
  • Any intestinal problem that would prevent the patient from eating one of the test diets (for example, gastric stapling that might prevent consumption of vegetables).
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00160108


Locations
Israel
Medical Center, The Nuclear Research Center
Dimona, Israel, 70700
Sponsors and Collaborators
The S. Daniel Abraham International Center for Health and Nutrition
Harvard School of Public Health
University of Western Ontario, Canada
Soroka University Medical Center
Brigham and Women's Hospital
Harvard Medical School
The Nuclear Research Center, Dimona
Ben-Gurion University of the Negev
Investigators
Principal Investigator: Iris Shai, RD, PhD Ben-Gurion University of the Negev
Study Chair: Meir J Stampfer, MD, DrPH Departments of Epidemiology and Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA
Study Chair: David Spence, MD Stroke Prevention & Atherosclerosis Research Centre, Robarts Research Institute, London, Canada
  More Information

Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

ClinicalTrials.gov Identifier: NCT00160108     History of Changes
Other Study ID Numbers: DR300-3
First Submitted: September 8, 2005
First Posted: September 12, 2005
Last Update Posted: September 13, 2006
Last Verified: September 2006